| TÍTULO |
PROGRAMA |
AÑO DE INICIO |
AÑO DE FINALIZACIÓN |
ROL SSPA |
| 3TR - Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions |
H2020-IMI2-Innovative Medicines Initiative 2 |
2019 |
2026 |
Coordinador |
| CIRCE - Joint action transfer of best practices in primary care. |
EU4 Health Programme |
2023 |
2026 |
Coordinador |
| Procure4Health - Healthcare Innovation Procurement Network. |
HE-Cluster 1- Health |
2022 |
2025 |
Coordinador |
| SIGNATURE - Single cells iN AuToimmUne inflammatoRy disEases. |
H2020-MSCA-Marie Slodowska-Curie Actions |
2023 |
2025 |
Coordinador |
| GenE-Humdi - Genome Editing to Treat Humans Diseases. |
COST- European Cooperation In Science And Technology |
2022 |
2026 |
Coordinador |
| EU-JAMRAI 2 - Joint Action Antimicrobial Resistance and Healthcare-Associated Infections 2 |
EU4 Health Programme |
2024 |
2027 |
Líder de WP |
| DrNanoDAll - Nanodiagnosis for Betalactam Hypersensitivity |
ERA-NET /JPI |
2020 |
2024 |
Coordinador |
| NIDS4HOSA: NIS deployment for Health Operator of Essential Services in Andalusia. |
CEF-Connecting Europe Facility |
2021 |
2024 |
Coordinador |
| Transthyretin Amyloid Cardiomyopathy Study (iTAC Study) |
International Atomic Energy Agency |
2021 |
2025 |
Coordinador |
| OriON - Joint Action on Contribution to the Cancer Inequalities Registry to Monitor National Cancer Control Policies |
EU4 Health Programme |
2024 |
2026 |
Socio |
| ASSESS-DHT - DEVELOPMENT AND HARMONISATION OF METHODOLOGIES FOR ASSESSING DIGITAL HEALTH TECHNOLOGIES IN EUROPE |
HE-CLUSTER 1- HEALTH |
2024 |
2026 |
Socio |
| eprObes - Preventing lifetime obesity by early risk-factor identification, prognosis and intervention |
HE-CLUSTER 1- HEALTH |
2023 |
2028 |
Socio |
| halt-RONIN - Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies |
HE-Cluster 1- Health |
2022 |
2026 |
Líder de WP |
| INIA – Intersex – New Interdisciplinary Approaches |
H2020-MSCA-Marie Slodowska-Curie Actions |
2020 |
2024 |
Líder de WP |
| PARENT PremAtuRe nEwborn motor and cogNitive impairmenTs: Early diagnosis |
H2020-MSCA-Marie Slodowska-Curie Actions |
2020 |
2024 |
Líder de WP |
| HI-PRIX - New pricingand payment models for cost-effective and affordable health innovations |
HE-Cluster 1- Health |
2023 |
2025 |
Líder de WP |
| PRIMAVERA - Vaccines and Monoclonal antibodies: Predicting the Impact on antimicrobial Resistance and an Economic. |
H2020-IMI2-Innovative Medicines Initiative 2 |
2021 |
2026 |
Líder de WP |
| PROVIDE - Prediction and prevention of cardiovascular diseases in pre-diabetes and diabetes |
EU4 Health Programme |
2023 |
2026 |
Socio |
| NFP4Health - JOINT ACTION ON INCREASING THE CAPACITY OF NATIONAL FOCAL POINTS (NFP) |
3rd Health Programme |
2021 |
2024 |
Líder de WP |
| iGAME - Multi-dimensional Intervention Support Architecture for Gamified eHealth and mHealth Products |
H2020-MSCA-Marie Slodowska-Curie Actions |
2019 |
2024 |
Líder de WP |
| TEAM-COACH: Training and Education in AntiMicrobial stewardship and infection prevention and COntrol in CHildren |
EU4 Health Programme |
2023 |
2025 |
Socio |
| REVERSE - pREVention and management tools for rEducing antibiotic Resistance in high prevalence Settings. |
H2020-SC1-Health, Demographic Change, and Wellbeing |
2022 |
2026 |
Socio |
| THCS - European Partnership on Transforming Health and Care System |
HE-Cluster 1- Health |
2023 |
2029 |
Socio |
| AMR-EDUCare - EduCation on Antimicrobial REsistance for the health workforce |
EU4 Health Programme |
2023 |
2025 |
Líder de WP |
| LUCIA. Understanding Lung Cancer related risk factors and their Impact |
HE- Misión Cáncer |
2023 |
2026 |
Socio |
| ERA4Health - Fostering a European Research Area for Health Research |
HE-Cluster 1- Health |
2022 |
2029 |
Socio |
| UNICOM - Up-scaling the global univocal identification of medicines. |
H2020-SC1-Health, Demographic Change, and Wellbeing |
2019 |
2024 |
Socio |
| IDERHA-Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance |
HE-IHI-INNOVATIVE HEALTH INITIATIVE |
2023 |
2028 |
Socio |
| CGI-Clinics - Data-driven cancer genome interpretation for personalised cancer treatment |
HE-Cluster 1- Health |
2022 |
2027 |
Socio |
| TRANSBIOLINE - Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease |
H2020-IMI2-Innovative Medicines Initiative 2 |
2019 |
2024 |
Socio |
| EUCAIM European Federation for Cancer Images |
Digital Europe Programme |
2023 |
2026 |
Socio |
| DIGI ID PLUS - Digital skills education to support better health and social inclusion outcomes for adults. |
EIT HEALTH |
2022 |
2024 |
Socio |
| PARC - European Partnership on the Assessment of Risks from Chemicals |
HE-Cluster 1- Health |
2022 |
2029 |
Socio |
| UNITED4SURVEILLANCE - Union and National Capacity Building 4 IntegraTED Surveillance |
EU4 Health Programme |
2023 |
2025 |
Socio |
| DDBIOS-Droplet Digital PCR and PCR-free BIOSensors for the diagnosis of resistance-associated SNPs in Pneumocystis jirovecii |
ACCIÓN ESTRATÉGICA EN SALUD 2021-2023 |
2024 |
2026 |
Socio |
| IntelliLung - Intelligent Lung Support for Mechanically Ventilated Patients in the Intensive Care Unit. |
HE-Cluster 1- Health |
2022 |
2027 |
Socio |
| Schools4Health |
EU4 Health Programme |
2022 |
2025 |
Socio |
| eCAN. Joint Action on strengthening ehealth including telemedicine and remote monitoring for health care systems for cancer prevention and care |
EU4 Health Programme |
2022 |
2024 |
Socio |
| GRIPonNASH - GRIP on NASH: Global Research Initiative for Patient Screening on NASH |
HE-IHI-INNOVATIVE HEALTH INITIATIVE |
2023 |
2027 |
Líder de WP |
| VACCELERATE - European Corona Vaccine Trial Accelerator Platform |
H2020-SC1-Health, Demographic Change, and Wellbeing |
2021 |
2024 |
Socio |
| NECESSITY - NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients. |
H2020-IMI2-Innovative Medicines Initiative 2 |
2019 |
2024 |
Socio |
| JANE. EU Joint Action on Networks of Expertise |
EU4 Health Programme |
2022 |
2024 |
Socio |
| CORE-MD - Coordinating Research and Evidence for Medical Devices. |
H2020-SC1-Health, Demographic Change, and Wellbeing |
2021 |
2024 |
Socio |
| RIBLES -Red Iberoamericana de Biomarcadores en Lupus Eritematoso Sistémico. |
CYTED- Redes Temáticas |
2021 |
2025 |
Socio |
| ResilNet-Resilience and vulnerability: from neural circuits to networks |
ERANETS/JPI- NEURON |
2024 |
2026 |
Socio |
| ODIN. Leveraging AI based technology to transform the future of health care delivery in Leading Hospitals in Europe |
H2020-LEIT-ICT-INFORMATION AND COMMUNICATION TECHNOLOGIES |
2023 |
2024 |
Socio |
| CARE4Diabetes - Reducing the burden of non-communicable diseases by providing a multi-disciplinary lifestyle treatment intervention for type 2 diabetes |
EU4 Health Programme |
2023 |
2026 |
Socio |
| AFFIRMO - Atrial Fibrillation Integrated Approach In Frail, Multimorbid, And Polymedicated Older People |
H2020-SC1-Health, Demographic Change, and Wellbeing |
2021 |
2026 |
Socio |
| HEALTH4EUKIDS - Joint action on the implementation of best practices and research results on prevention of non-communicable diseases and risk factors: health promotion and obesity prevention. |
EU4 Health Programme |
2022 |
2025 |
Socio |
| IMPLEMENTAL - JA-02-2020 - JA on Implementation of Best Practices in the area of Mental Health. |
3rd Health Programme |
2021 |
2024 |
Socio |
| P2Med - IMIBIC Fellowship Programme for Personalised and Precision Medicine |
H2020-MSCA-Marie Slodowska-Curie Actions |
2019 |
2025 |
Único beneficiario |
| LRH-1/NR5A2_mediated immune coupied remodelling a wound healing |
Cures |
2023 |
2026 |
Único beneficiario |
| ASSERT - Development of a nanotechnology-based innovative assay for the diagnosis of allergy to Betalactams |
H2020-MSCA-Marie Slodowska-Curie Actions |
2021 |
2024 |
Único beneficiario |
| Real-life effectiveness of BIC/FTC/TAF in naïve patients with CD4+ less than 200 cells/mL or AIDS events |
Fellowship Program |
2021 |
2024 |
Único beneficiario |
| onco-inflammation - Origin of genomic instability: Understanding the biological influence of inflammation in the initiation of pancreatic tumorigenesis. |
H2020-MSCA-Marie Slodowska-Curie Actions |
2022 |
2024 |
Único beneficiario |
| ¿CÓMO INFLUYE LA MICROBIOTA INTESTINAL EN EL DESARROLLO DE LA ARTRITIS IDOPÁTICA JUVENIL? |
Award |
2016 |
2024 |
Único beneficiario |
| CRYSTAL3_Commercial & Research Opportunity for Cysteinyl Leukotriene Signalling in Ocular & CNS Dysfunction, Cancer and Cardiovascular Disease. |
H2020-MSCA-Marie Slodowska-Curie Actions |
2021 |
2024 |
Único beneficiario |